University of Wisconsin–Madison

Certificate in Formulary Drug Evaluation Processes

Essential Skills for evidence-based formulary decision-making within Pharmacy and Therapeutics committees

Healthcare professional taking notes for formulary drug evaluationPharmacy and Therapeutics (P&T) committees help determine which drugs will be included in a drug formulary. They operate in various settings such as hospitals and managed care organizations. Committee members come from a wide variety of backgrounds. They can be physicians, nurses, pharmacists, scientists and others in the healthcare industry.

This causes variances in practices for clinicians who contribute to P&T committees. Implementing a consistent operating and training program for committee members can be challenging. P&T Committee members must understand how to evaluate the medical literature and use evidence-based practice to make formulary decisions.

Both committee members and non-members make significant contributions to the drug evaluation and formulary management process. In partnership with the University of Illinois-Chicago, the University of Wisconsin is proud to offer the  “Certificate in Formulary Drug Evaluation Processes” to provide clarity and structure to the evidence evaluation process. The curriculum is designed to improve decision making among all contributors. This 100% online certificate program provides you with training in evidence-based decision making. Upon completion, you will gain skills critical to the formulary drug selection process.

Through a series of eight modules, taken at your own pace you will receive training in the following areas:

  • Creating drug evaluation and selection strategies
  • Development of committee materials
  • Strategies for searching and evaluating medical literature
  • Applying medical evidence to decision making

Developed & Conducted by the University of Illinois at Chicago in cooperation with the Division of Pharmacy Professional Development, School of Pharmacy, University of Wisconsin-Madison.

Registration Information


Refund Policy

Course date:Jan 11, 2022 - Dec 1, 2024
Course fee:

$950 Healthcare professionals (please contact us for group rates)

$475 Academic rate

$275 Pharmacy residents

This course is online and self-paced. You may register at any time and complete the curriculum at your own pace by December 31, 2024.

Course Objectives

Upon completing this course, you will be able to:

1.    Recognize the differences in types of members and clinical drug evaluation processes of Pharmacy and Therapeutics Committees within various healthcare settings.

2.    Explain the scientific and practical aspects one should consider when clinically evaluating drugs.

3.    Summarize the skills required to conduct a thorough search of medical literature, as well as identify valid and reliable medical information sources.

4.    Describe the process of systematically evaluating, through various tools, the medical literature for inclusion within a clinical drug evaluation.

5.    Critique the recommended components of a drug class evaluation document.

Who Should Attend

  • Clinicians seeking to expand their skills in the retrieval, evaluation, and application of biomedical information in the context of formulary management
  • Clinicians who wish to strengthen their ability to author effective and thorough drug monographs and class review documents for consideration by P&T Committees
  • Employees in healthcare settings who are not members of but contribute to P&T Committees and who wish to improve their value to the Committee through a better understanding of formulary management
  • Entire P&T Committees who desire to ensure all members possess a consistent level of education in literature evaluation and formulary management 

Course Outline

Training Modules

The training program modules are listed below.  Students will be tested for learning at the end of each module. A certificate is awarded upon successful completion of all modules.

  • Module 1: Structure and function of the P&T Committee
  • Module 2: Strategies for formulary management
  • Module 3: Anatomy of a drug class review
  • Module 4: Review of clinical trial designs
  • Module 5: Basic biostatistical methods
  • Module 6: Critical analysis of medical literature
  • Module 7: Medical literature searching
  • Module 8: Pharmacoeconomics


Janna Afanasjeva, PharmD, BCPS
Clinical Assistant Professor
University of Illinois at Chicago

Dr. Randy Hatton, BPharm, PharmD, FCCP, BCPS
Clinical Professor
University of Florida, College of Pharmacy

Heather Ipema, PharmD, BCPS
Clinical Assistant Professor
University of Illinois at Chicago

Brett Kelly, BS Pharm, MS,
Clinical Associate Professor
University of Wisconsin School of Pharmacy

Mary Lynn Moody, BS Pharm,
Clinical Associate Professor and Clinical Pharmacist
Pharmacy Practice University of Illinois at Chicago

Ryan Rodriguez, PharmD, BCPS
Clinical Assistant Professor
University of Illinois at Chicago

Dr. Samantha Spencer, PharmD, BCPS
Clinical Associate Professor
University of Illinois at Chicago
College of Pharmacy Drug Information Group (DIG)

Dan Touchette, PharmD, MA
Associate Professor of Pharmacy Systems Outcomes and Policy and Pharmacy Practice
University of Illinois at Chicago

Policy on Disclosure

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

For this accredited continuing education activity, all faculty, planners, and other persons who may influence content of this activity have no relevant financial relationships with ineligible companies to disclose.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.

CE Credit

ICEP LogoAccreditation Statement

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Accreditation Council for Pharmacy Education (ACPE)

The University of Wisconsin–Madison ICEP designates this enduring knowledge based activity for 15.00 hours or 1.5 CEUs of CPE credit. Credit can be earned by successfully completing the activity, the assessment and the evaluation. There will be no partial credit awarded for partial completion.

UAN: JA0000358-19-021-H04-P,  (15.00 hours or 1.5 CEUs)

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 1.5 CEUs or 15 hours.

Program Coordinator

Eric Buxton, PhD

Division of Pharmacy Professional Development
777 Highland Avenue
Madison, WI 53705
(608) 262-2431 FAX
(608) 265-2259